BILL ANALYSIS

HR6322

NEUTRAL

Stop Stealing our Chips Act

HR6322 (Stop Stealing our Chips Act) has been assessed with a neutral outlook for investors. This legislation directly affects Advanced Micro Devices ($AMD), Intel ($INTC), NVIDIA ($NVDA) and Taiwan Semiconductor ($TSM). The primary sectors impacted are Technology. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

No new funding or restrictions — pure compliance cost impact

Bipartisan 43-1 committee vote signals high probability of House passage

Zero direct revenue impact for any company; minimal operational overhead increase

How HR6322 Affects the Market

The bill is a procedural compliance requirement with negligible near-term market impact. Real market data shows the semiconductor sector in a powerful uptrend independent of this legislation: NVDA at $213.17 (+27.25% 30-day), AMD at $323.21 (+60.01% 30-day), INTC at $84.52 (+95.97% 30-day), TSM at $392.34 (+20.08% 30-day). These moves are driven by AI tailwinds, not congressional whistleblower programs. No trading action is warranted based on HR6322 alone.

Bill Details

Metric	Value
Bill Number	HR6322
Market Sentiment	neutral
Event Date	November 28, 2025
Affected Sectors	Technology
Affected Stocks	Advanced Micro Devices ($AMD), Intel ($INTC), NVIDIA ($NVDA), Taiwan Semiconductor ($TSM)
Source	View on Congress.gov →

Summary

Stop Stealing our Chips Act (HR6322) establishes a whistleblower program for export control violations on advanced AI chips but allocates no new funding and imposes no new restrictions. Compliance costs increase marginally for affected chip exporters, with no immediate financial gains or losses for major semiconductor companies.

Full AI Market Analysis

The Stop Stealing our Chips Act (HR6322) was introduced November 28, 2025, and ordered to be reported out of committee (amended) on April 22, 2026, by a 43-1 vote, indicating strong bipartisan momentum. The bill creates a whistleblower incentive program at the Department of Commerce's Bureau of Industry and Security (BIS) to reward individuals reporting export control violations related to advanced AI chips. It does not appropriate new funding, impose new export restrictions, or authorize any spending. The legislative path requires House floor action, then Senate consideration of companion bill S1473; no final enactment is certain. The money trail is absent — the bill neither authorizes nor appropriates any direct federal spending. Its operational impact is limited to increased compliance costs for companies in the advanced AI chip export chain. This includes major U.S. semiconductor firms and foundries like NVIDIA, AMD, Intel, and TSMC. No specific dollar amounts are tied to the bill; the Financial impact is an increase in legal, audit, and monitoring costs rather than revenue changes. Real market data shows a strong bullish trend across the semiconductor sector: NVIDIA is up 27.25% over 30 days to $213.17 (near its 52-week high of $216.83); AMD has surged 60.01% to $323.21; Intel has soared 95.97% to $84.52; and TSMC has risen 20.08% to $392.34. These moves are driven by AI demand and broader sector tailwinds, not by this procedural bill. The bill's passage would not alter these fundamentals. The Presidential Memorandum of April 20, 2026, under the Defense Production Act, focuses on large-scale energy and infrastructure, not semiconductor export controls. It does not directly amplify or conflict with HR6322. The executive action stimulates domestic energy investment, which could increase demand for semiconductor content in energy infrastructure, but that is an indirect and distant linkage. Competitive positioning: Companies with heavy exposure to advanced AI chip exports facing heightened scrutiny include NVIDIA and AMD. Intel and TSMC face less direct exposure but will absorb incremental compliance costs. The bill does not shift competitive advantage between these firms. Legislative timeline: House floor vote expected within weeks; Senate companion bill is in committee. Probability of enactment is moderate given bipartisan committee support.